Sign in

CIK 0001612042

  • Large accelerated filer

Ascendis Pharma A/S

Sign in to watch
Ticker
ASND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Denmark
Entity type
Other
Phone
+45 70222244
Business address
TUBORG BOULEVARD 12, HELLERUP, Denmark
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,150,625
in 3 filings

Net −$6,150,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG EVP & Chief Admin Officer Exercise or conversion +20,000 $37.18 $744K 39,460
2026-11-17 PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG EVP & Chief Admin Officer Sale −20,000 $263.89 $5.3M 19,460
2026-11-17 PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG EVP & Chief Admin Officer Exercise or conversion · Warrants −20,000 0
2026-09-08 Bodenhoff Mads SVP & PAO Exercise or conversion +3,000 $110.00 $330K 3,000
2026-09-08 Bodenhoff Mads SVP & PAO Sale −3,000 $270.19 $811K 0
2026-09-08 Bodenhoff Mads SVP & PAO Exercise or conversion · Warrants −3,000 687
2026-09-02 HOLTUG LARS Director Sale −236 $264.13 $62K 4,000
2026-08-14 BIENAIME JEAN JACQUES Director Purchase +1,100 $245.85 $270K 2,000
2026-08-14 BIENAIME JEAN JACQUES Director Purchase +900 $246.91 $222K 2,900
2026-06-02 SMITH SCOTT THOMAS EVP & Chief Financial Officer Purchase +100 $219.00 $22K 4,367
2026-05-29 BIENAIME JEAN JACQUES Director Purchase +200 $223.76 $45K 600
2026-05-29 BIENAIME JEAN JACQUES Director Purchase +200 $222.30 $44K 800
2026-05-29 BIENAIME JEAN JACQUES Director Purchase +100 $223.50 $22K 900
2026-05-29 SMITH SCOTT THOMAS EVP & Chief Financial Officer Purchase +250 $223.32 $56K 4,267
2026-05-26 BIENAIME JEAN JACQUES Director Purchase +200 $236.24 $47K 200
2026-05-26 BIENAIME JEAN JACQUES Director Purchase +200 $239.37 $48K 400
2026-05-11 JENSEN FLEMMING STEEN Sale −19,460 $238.49 $4.6M 0
2026-04-14 BIENAIME JEAN JACQUES Director Returned to the company · Warrants −9,160 0
2026-04-14 BIENAIME JEAN JACQUES Director Grant or award · Warrants +9,160 9,160

Page 1 of 1 · 19 trades